Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Breakthrough intramolecular cross-dehydrogenation coupling method enables efficient production of coumarin heteroaromatic compounds with significant cost reduction and enhanced supply chain reliability.
Patent CN115872905A enables high-purity API intermediate production with TON=100,000, reducing manufacturing costs and supply chain lead time through green catalysis.
Patent CN114436949B enables mild ester hydrogenation with high stability, reducing catalyst costs and improving supply chain reliability for fine chemical manufacturing.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover how new buparvaquone synthesis achieves 60%+ yield and 99.5% purity without silver catalysts. Reduce costs and supply chain risks for bovine Taylor disease treatment.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Solve supply chain risks for this key API intermediate with a 3-step industrial synthesis. 100% yield in first step, 51.3% in final step. Contact for GMP production.
Solve supply chain risks with this 3-step, column-free synthesis of 5-ethyl-2-pyrrole carboxylic acid. 92% yield, no chromatography, and scalable to 100MT/yr. Contact for COA/MSDS.
Solve supply chain challenges for (Z)-2-acetylaminocinnamic acid methyl ester with 68%+ yield, 99%+ purity, and no column chromatography. Industrial-scale production ready.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Solve supply chain risks and low yields in anticancer intermediate production. Discover a 4-step, 84% yield route using common raw materials. Contact us for scalable CDMO solutions.
Solve amine synthesis challenges with 90%+ yield, room-temperature process, and 15x solvent reuse. Reduce waste & costs for pharma supply chains.
Solve high-temperature, low-yield issues in quinoline synthesis with yttrium-catalyzed dehydrogenation. Achieve 90% yield, reduced tar, and scalable production for pharmaceutical intermediates.
Solve high-temperature dehydrogenation challenges with yttrium-catalyzed process: 90% yield, reduced tar byproducts, and 53-57°C operation for stable API supply chains.
Solve low-yield and harsh conditions in enamide synthesis. Our CDMO expertise scales this palladium-catalyzed method with 60-81% yields, reducing costs and supply chain risks for API manufacturing.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Solve supply chain gaps for (2S)-2-amino-4-cyclopropylbutyric acid with novel Suzuki coupling. 99.4% purity, 91.6% yield, and no special equipment required for GMP production.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Reduce production costs by 30% with this Pd/C-catalyzed miglitol process. 99.9% purity, 97% yield, and no biological oxidation steps. Contact for CDMO scale-up.